Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF - PubMed (original) (raw)
. 1995 Dec 26;217(3):721-7.
doi: 10.1006/bbrc.1995.2832.
Affiliations
- PMID: 8554590
- DOI: 10.1006/bbrc.1995.2832
Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF
B Liu et al. Biochem Biophys Res Commun. 1995.
Abstract
Tumour-secreted vascular endothelial growth factor (VEGF) exerts a number of effects which are important in tumour pathology, including stimulation of angiogenesis and permeabilisation of tumour-associated vasculature. In this study we have examined the possibility that VEGF may also play an autocrine role in tumour growth. Using reverse-transcriptase polymerase chain reaction (RT-PCR), the expression of VEGF was found in 15/15 human tumour cell lines examined, while the VEGF receptor KDR was detected only in three melanoma cell lines (MeWo and A375, both wild type and metastatic variant). Exogenously added VEGF (10ng/ml) was able to stimulate up to 40% increased proliferation of A375 M melanoma cells following a 48-h period of quiescence, suggesting that VEGF may indeed play a role in autocrine, as well as paracrine, stimulation of melanoma growth.
Similar articles
- Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X, Song S, Wu J, Meng L, Dong Z, Shou C. Tian X, et al. Biochem Biophys Res Commun. 2001 Aug 24;286(3):505-12. doi: 10.1006/bbrc.2001.5409. Biochem Biophys Res Commun. 2001. PMID: 11511087 - Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW, Simpson DA, Boocock C, Gardiner TA, Murphy GM, Archer DB. Stitt AW, et al. J Pathol. 1998 Nov;186(3):306-12. doi: 10.1002/(SICI)1096-9896(1998110)186:3<306::AID-PATH183>3.0.CO;2-B. J Pathol. 1998. PMID: 10211121 - VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours.
Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. Ohta Y, et al. Br J Cancer. 1999 Sep;81(1):54-61. doi: 10.1038/sj.bjc.6690650. Br J Cancer. 1999. PMID: 10487612 Free PMC article. - pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth.
Pouysségur J, Franchi A, Pagès G. Pouysségur J, et al. Novartis Found Symp. 2001;240:186-96; discussion 196-8. doi: 10.1002/0470868716.ch13. Novartis Found Symp. 2001. PMID: 11727929 Review. - [Regulation of melanoma growth].
Paloheimo M, Saksela O, Pyrhönen S, Alitalo K. Paloheimo M, et al. Duodecim. 1992;108(23-24):2097-104. Duodecim. 1992. PMID: 1345291 Review. Finnish. No abstract available.
Cited by
- Complications of Injected Exogenous Growth Factor for Cosmetic Facial Rejuvenation: A Case Series and Sequential Therapy.
Long J, Zhang Z, Pei J, Xiao B, Xue P, Yang Q, Fan X, Song B. Long J, et al. Aesthetic Plast Surg. 2024 Feb;48(3):440-450. doi: 10.1007/s00266-023-03630-6. Epub 2023 Sep 28. Aesthetic Plast Surg. 2024. PMID: 37770636 - Targeted Therapy for Melanomas Without BRAF V600 Mutation.
Choi JS, Chandra S. Choi JS, et al. Curr Oncol Rep. 2022 Dec;24(12):1873-1881. doi: 10.1007/s11912-022-01306-z. Epub 2022 Nov 26. Curr Oncol Rep. 2022. PMID: 36435868 Review. - Old Player-New Tricks: Non Angiogenic Effects of the VEGF/VEGFR Pathway in Cancer.
Ntellas P, Mavroeidis L, Gkoura S, Gazouli I, Amylidi AL, Papadaki A, Zarkavelis G, Mauri D, Karpathiou G, Kolettas E, Batistatou A, Pentheroudakis G. Ntellas P, et al. Cancers (Basel). 2020 Oct 27;12(11):3145. doi: 10.3390/cancers12113145. Cancers (Basel). 2020. PMID: 33121034 Free PMC article. Review. - Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma.
Kakadia S, Yarlagadda N, Awad R, Kundranda M, Niu J, Naraev B, Mina L, Dragovich T, Gimbel M, Mahmoud F. Kakadia S, et al. Onco Targets Ther. 2018 Oct 17;11:7095-7107. doi: 10.2147/OTT.S182721. eCollection 2018. Onco Targets Ther. 2018. PMID: 30410366 Free PMC article. Review. - Molecular Targeted Therapy Approaches for BRAF Wild-Type Melanoma.
Johnpulle RA, Johnson DB, Sosman JA. Johnpulle RA, et al. Curr Oncol Rep. 2016 Jan;18(1):6. doi: 10.1007/s11912-015-0485-6. Curr Oncol Rep. 2016. PMID: 26743513 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical